Full Text View
Tabular View
No Study Results Posted
Related Studies
Phase I Study of IMP321 Given Alone or as an Adjuvant to a Reference Flu Antigen
This study has been completed.
Study NCT00354263   Information provided by Immutep S.A.

First Received on July 19, 2006.   Last Updated on April 23, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Healthy
Interventions listed in this trial
IMP321
saline
Additional drug interventions recognized in this trial
Adjuvants, Immunologic
More general drug interventions related to this trial
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Immutep S.A.
SGS Aster-Cephac (CRO)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services